This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2viw
From Proteopedia
| Line 1: | Line 1: | ||
| - | == | + | ==Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator== |
<StructureSection load='2viw' size='340' side='right' caption='[[2viw]], [[Resolution|resolution]] 2.05Å' scene=''> | <StructureSection load='2viw' size='340' side='right' caption='[[2viw]], [[Resolution|resolution]] 2.05Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| Line 32: | Line 32: | ||
</div> | </div> | ||
<div class="pdbe-citations 2viw" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 2viw" style="background-color:#fffaf0;"></div> | ||
| - | |||
| - | ==See Also== | ||
| - | *[[Urokinase|Urokinase]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 47: | Line 44: | ||
[[Category: Frederickson, M]] | [[Category: Frederickson, M]] | ||
[[Category: Matthews, J E]] | [[Category: Matthews, J E]] | ||
| - | [[Category: | + | [[Category: McMenamin, R]] |
[[Category: Smith, D]] | [[Category: Smith, D]] | ||
[[Category: Vinkovic, M]] | [[Category: Vinkovic, M]] | ||
| Line 58: | Line 55: | ||
[[Category: Inhibitor]] | [[Category: Inhibitor]] | ||
[[Category: Kringle]] | [[Category: Kringle]] | ||
| + | [[Category: Pharmaceutical]] | ||
[[Category: Phosphorylation]] | [[Category: Phosphorylation]] | ||
[[Category: Plasminogen activation]] | [[Category: Plasminogen activation]] | ||
| + | [[Category: Polymorphism]] | ||
[[Category: Protease]] | [[Category: Protease]] | ||
[[Category: Secreted]] | [[Category: Secreted]] | ||
Revision as of 07:25, 16 November 2017
Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator
| |||||||||||
Categories: Human | U-plasminogen activator | Callaghan, O | Chessari, G | Congreve, M | Cowan, S R | Frederickson, M | Matthews, J E | McMenamin, R | Smith, D | Vinkovic, M | Wallis, N G | Blood coagulation | Egf-like domain | Fibrinolysis | Glycoprotein | Hydrolase | Inhibitor | Kringle | Pharmaceutical | Phosphorylation | Plasminogen activation | Polymorphism | Protease | Secreted | Serine protease | Urokinase-type plasminogen activator | Zymogen
